Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
Park W, Mezquita L, Okabe N, Chae YK, Kwon D, Saravia D, Auclin E, Planchard D, Caramella C, Ferrara R, Agte S, Oh M, Mudad R, Jahanzeb M, Suzuki H, Besse B, Lopes G.
Park W, et al.
Br J Cancer. 2020 Feb;122(3):340-347. doi: 10.1038/s41416-019-0643-y. Epub 2019 Nov 25.
Br J Cancer. 2020.
PMID: 31761899
Free PMC article.